Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01902888 · ClinicalTrials.gov registry record
Evaluation of GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm
A clinical trial, sponsored by W.L.Gore & Associates.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01902888 is a clinical trial that was terminated before completion, run by W.L.Gore & Associates. The registered enrollment target is 3 participants.
The verdict
NCT01902888 was terminated before completion, sponsored by W.L.Gore & Associates.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This is a multicenter, non-randomized, single arm, retrospective study of GORE® VIABAHN® Endoprosthesis for the treatment of a Popliteal Artery Aneurysm (PAA).
Interventions
- DEVICE GORE® VIABAHN® Endoprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01902888
The ClinicalTrials.gov registry entry for NCT01902888 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GORE® VIABAHN® Endoprosthesis is the first listed.
NCT01902888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01902888 about?
NCT01902888 is a clinical study titled "Evaluation of GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm". This is a multicenter, non-randomized, single arm, retrospective study of GORE® VIABAHN® Endoprosthesis for the treatment of a Popliteal Artery Aneurysm (PAA).
What is the current status of trial NCT01902888?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2013-07. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01902888?
The interventions under investigation include: GORE® VIABAHN® Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT01902888?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.